Matt Stahl

Matt Stahl is the Chief Executive Officer at Steel Therapeutics.

Previously, Matt was Associate Project Manager, Medical & Scientific Strategy at BluPrint Oncology.

Matt attended a College of Pharmacy from University of Iowa.